FINAL PROGRAMME – 33RD ECCMID Copenhagen, Denmark 2023 1 ADDENDUM 2 Abstracts 2233-2916ABSTRACTS2 Abstracts Nr & Co-authors Presentation Nr TitlePresenterDateTime Inter- vention LocationSession Code Session TypeSessionSession Time 2233P1281 Heterologous expression of Mycoplasma pneumo- niae major adhesins in the close related species Mycoplasma genitalium Marina Mar- cos-Silva 16-04-202312:00 Poster Area PS012 Poster Session 2c. Community-acquired respira- tory infections (incl. epidemiology, clinical, imaging, treatment & prevention) 12:00 Marina Marcos-Silva (1, 2), Jesús Jiménez-Jordán (1, 2), David Vizárraga (3), Ignacio Fita (3), Oscar Q Pich (1, 4), Jaume Piñol (1, 2) - (1) Institut De Biotecnologia I Biomedicina, Universitat Autònoma De Barcelona, Spain, (2) Departament De Bioquímica I De Biologia Molecular, Universitat Autònoma De Barcelona, Spain, (3) Instituto De Biología Molecular De Barcelona (Ibmb-Csic), Parc Científic De Barcelona, Spain, (4) Laboratori De Recerca En Microbiologia I Malalties Infeccioses, Institut D’Investigació I Innovació Parc Taulí (I3Pt), Hospital Universitari Parc Taulí, Universitat Autònoma De Barcelona, Spain 2234P3098 Evaluation of a commercial IgG monotest assay: a new automated chemiluminescent immunoassay for the serodiagnosis of cystic echinococcosis Sabrina Egrek17-04-202312:00 Poster Area PS048 Poster Session 7b. Diagnostic parasitology (incl. traditional, molecular and other methods) 12:00 Sabrina Egrek (1, 2), Rosalie Sacheli (1, 2), Françoise Toussaint (1), Elise Beaumaikers (1), Jean-Baptiste Giot (3, 2), Philippe Léonard (3, 2), Olivier Detry (4, 2), Carine Truyens (5), Marie-Pierre Hayette (1, 2) - (1) National Reference Laboratory For Echinococcosis, Department Of Clinical Microbiology, University Hospital Of Liège, Belgium, (2) Echinoliege, Multidisciplinary Management Group, University Hospital Of Liège, Belgium, (3) Department Of Internal Medicine And Infectiology, Chu Liège, Belgium, (4) Department Of Abdominal Surgery And Transplantation, Chu Liège, Belgium, (5) Laboratory Of Parasitology, Université Libre De Bruxelles, Belgium 2235P2875 Comparison of conventional, serological and mole- cular methods for the diagnosis of herpes zoster Sailaxmi Maha- patra 17-04-202312:00 Poster Area PS004 Poster Session 1d. Herpesviruses (incl. diagno- stics & epidemiology, antiviral drugs, treatment & susceptibility/ resistance, excl. clinical studies in immunocompromised hosts) 12:00 Sailaxmi Mahapatra, Aashish Choudhary - (1) Aiims, New Delhi, India 2236P0748 Cost analysis of health care-acquired infections in a teaching hospital: a comparison of methods Guglielmo Giraldi 15-04-202312:00 Poster Area PS059 Poster Session 8e. Hospital epidemiology, trans- mission, surveillance & screening (incl. environment) 12:00 Guglielmo Giraldi (1), Montesano Marzietta (2), Francesca Maria Forestiero (1), Maria Assunta Donato (1), Paolo Lombardo (1), Francesco Stella (2), Giovanni Battista Orsi (1) - (1) Department Of Public Health And Infectious Disease, Sapienza University Of Rome, Italy, (2) Teaching Hospital Sant’Andrea, Sapienza University Of Rome, Italy 2239P0156 In vitro activity of apramycin against 16S-RMTa- se-producing Gram-negative isolates Francois Caméléna 15-04-202312:00 Poster Area PS019 Poster Session 3b. Resistance surveillance and epidemiology: Gram-negatives 12:00 Francois Caméléna (1, 2), Mathilde Liberge (1), Inès Rezzoug (1), Manel Merimèche (1), Thierry Naas (3), Béatrice Berçot (1, 2) - (1) Laboratoire De Bactériologie, Hôpitaux Saint-Louis - Lariboisière, Aphp, France, (2) Université Paris Cité, Inserm, Iame, Umr 1137 , France, (3) Laboratoire De Bactériologie, Hôpital Kremlin Bicêtre, Aphp, France 2242P1844 Microbial cell-free DNA sequencing as an addition to conventional diagnostics in neonatal sepsis Julian Balks16-04-202312:00 Poster Area PS033 Poster Session 4h. Clinical metagenomics12:00 Julian Balks (1), Andreas Müller (1), Silke Grumaz (2), Florian Kipfmüller (1) - (1) University Hospital Bonn, Germany, (2) Noscendo Gmbh, Germany 2244E1242 Comparison of genetic and phenotypic characte- ristics of Salmonella enterica serovar Choleraesuis isolated in humans and animals from 2006 to 2021: a One Health approach for antimicrobial resistance surveillance Camille Jac- queline 18-04-202311:12Arena 3EF256 1-hour ePoster Flash Session Evolving epidemiology of drug-re- sistant enteric pathogens 11:00 Camille Jacqueline (1, 2), Clara Samper Cativiela (3), Julio Alvarez Sanchez (3), Silvia Herrera Leon (1) - (1) Centro Nacional De Microbiología, Instituto De Salud Carlos Iii, Spain, (2) 2. European Public Health Microbiology Training Programme (Euphem), European Centre For Disease Prevention And Control (Ecdc), Sweden, (3) Centro De Vigilancia Sanitaria Veterinaria (Visavet), Universidad Complutense De Madrid, Spain 2246P1469 Discriminatory diagnosis of tick-borne infectious disease coinfections and cross-reactions in Korea Da Young Kim16-04-202312:00 Poster Area PS016 Poster Session 2g. Zoonotic bacterial infections (incl. foodborne, waterborne and vector-borne pathogens, veteri- nary microbiology and One Health aspects, excl. AMR) 12:00 Da Young Kim (1), Jun-Won Seo (1), Na Ra Yun (1), Choon-Mee Kim (2), Dong-Min Kim (1) - (1) Department Of Internal Medicine, Chosun University College Of Medicine, Korea, Republic Of, (2) Department Of Premedical Science, College Of Medicine, Chosun University, Korea, Republic Of 2247P3163 Inderterminate HIV serologic profiles and serocon- version onPrEP Mathilde Roussel 18-04-202312:00 Poster Area PS094 Poster Session 13a. Viral infections12:00 Mathilde Roussel, Benoit Visseaux, Stéphanie Haïm Boukobza, Sabine Trombert, Laura Verdurme, Camille D‘Humières, Bénédicte Roquerbert - (1) Cerba, France 2248P2202 Probability of target attainment of cefepime/ enmetazobactam to support dose selection for the treatment of pulmonary infections Juan Quevedo17-04-202312:00 Poster Area PS037 Poster Session 5b. Pharmacokinetics/pharma- codynamics of antibacterial drugs & therapeutic drug monitoring 12:00 Juan Quevedo (1), Nathalie Dunkel (1), Adam Belley (2), Patrick Velicitat (2), Matthias Machacek (3), Anne Santerre Henriksen (4), Jannik Vollmer (3) - (1) Advanz Pharma Uk, United Kingdom, (2) Allecra Therapeutics, France, (3) Lyo-X Ag, Switzerland, (4) Maxel Consulting Aps, Denmark 2249E0221 Assessment of implementation strategies adopted for antimicrobial stewardship interventions in long-term care facilities: a systematic review Gabriel Birgand15-04-202313:48Arena 2EF048 1-hour ePoster Flash Session Antibiotic stewardship: anything you always wanted to know 13:30 Michele Conlin (1), Marie Hamard (2), Nelly Agrinier (3), Gabriel Birgand (4) - (1) Chu Nantes, France, (2) Hopital Bichat Claude Bernard, France, (3) Université De Lorraine, France, (4) Centre D’Appui À La Prévention Des Infections Associées Aux Soins Des Pays De La Loire, France 2250E1179 Combination of high-dose daptomycin and ceftri- axone for cardiac implantable electronic devices: a 10-year single-center experience Giacomo Ponta18-04-20239:42Arena 4EF238 1-hour ePoster Flash Session Surgical site, device infections and more 9:30 Giacomo Ponta (1, 2), Martina Ranzenigo (1, 2), Alessandra Marzi (3), Chiara Oltolini (2), Chiara Tassan Din (2), Caterina Uberti-Foppa (1, 2), Vincenzo Spagnuolo (1, 2), Laura Galli (1, 2), Patrizio Mazzone (3), Paolo Della Bella (2), Paolo Scarpellini (3), Antonella Castagna (1, 2), Marco Ripa (1, 2) - (1) San Raffaele Vita-Salute University, Italy, (2) Irccs San Raffaele Scientific Institute, Department Of Infectious Diseases, Italy, (3) Irccs San Raffaele Scientific Institute, Department Of Cardiac Electrophysiology, Italy 2252P0992 Moraxella catarrhalis disrupts airway epithelial barrier by destabilising F-actin in lung epitheli- alcells Jin-Han Yu15-04-202312:00 Poster Area PS065 Poster Session 9b. Host-pathogen interaction (incl. basic microbiome studies, animal models) 12:00 Jin-Han Yu, Ying-Chun Xu, Ya-Li Liu - (1) Peking Union Medical College Hospital, China 2253O0781 GES-52, a novel GES-type β-lactamase conferring resistance to ceftazidime/avibactam and ceftolo- zane/tazobactam combinations inPseudomonas aeruginosa Mustafa Sadek17-04-20239:18Hall NOS158 2-hour Oral Session Last line antibiotics against pan- drug resistant Gram-negative bacteria 8:30 Mustafa Sadek (1, 2), Alaaeldin Mohamed Saad (1, 3), Claudine Fournier (1, 4), Patrice Nordmann (1, 5, 6), Laurent Poirel (1, 5) - (1) Medical And Molecular Microbiology, Faculty Of Science And Medicine, University Of Fribourg, Switzerland, (2) Department Of Food Hygiene And Control, Faculty Of Veterinary Medicine, South Valley University, Egypt, (3) Department Of Zoonoses, Faculty Of Veterinary Medicine, Zagazig University, Egypt, (4) Hôpital Fribourgeois-Hôpital Cantonal De Fribourg, Switzerland, (5) Switzerland National Reference Center For Emerging Antibiotic Resistance (Nara), University Of Fribourg, Switzerland, (6) Institute For Microbiology, University Of Lausanne And University Hospital Centre, Switzerland 2254P0382 Evaluation of the antibacterial activity of bacterio- cins as a new therapeutic option for the treatment ofMycobacterium abscessus infections in patients with cystic fibrosis Anandi Martin15-04-202312:00 Poster Area PS020 Poster Session 3c. Susceptibility testing methods (incl. assay validation, phenotypic assays and comparative studies, excl. TB) 12:00 Anandi Martin (1), Imane Saadalbichr (2), Alexia Verroken (2), Philippe Gabant (1), Hector Rodriguez-Villalobos (2) - (1) Syngulon, Belgium, (2) Microbiology Department, Cliniques Universitaires Saint-Luc And Institute Of Experimental And Clinical Research (Irec) Université Catholique De Louvain (Uclouvain), Belgium 2255P2084 Fungal translocation measured by serum 1,3-ß-D- glucan is associated with severity and outcome of liver cirrhosis: a pilot study Matthias Egger16-04-202312:00 Poster Area PS046 Poster Session 6e. Basic mycology (incl. in vitro and in vivo studies, pathogenesis) 12:00 Matthias Egger (1, 2), Angela Horvath (3), Florian Prüller (4), Peter Fickert (3), Jürgen Prattes (1), Robert Krause (1, 2), Martin Hönigl (1), Vanessa Stadlbauer (3) - (1) Medical University Of Graz, Division Of Infectious Diseases, Austria, (2) Biotechmed, Austria, (3) Medical University Of Graz, Division Of Gastroenterology And Hepatology, Austria, (4) Medical University Of Graz, Clinical Institute Of Medical And Chemical Laboratory Diagnostics, AustriaFINAL PROGRAMME – 33RD ECCMID Copenhagen, Denmark 2023 3 CategorySub-categoryLink AbstractsLink EposterLink Oral Session 02. Bacterial infection & disease 2c. Community-acquired respiratory infections (incl. epidemiology, clinical, imaging, treatment & prevention) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13395&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1281 Molecular, Universitat Autònoma De Barcelona, Spain, (3) Instituto De Biología Molecular De Barcelona (Ibmb-Csic), Parc Científic De Barcelona, Spain, (4) Laboratori De Recerca En Microbiologia I Malalties Infeccioses, Institut D’Investigació I Innovació Parc Taulí 07. Parasitic diseases & global health 7b. Diagnostic parasitology (incl. traditi- onal, molecular and other methods) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13396&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P3098 artment Of Clinical Microbiology, University Hospital Of Liège, Belgium, (2) Echinoliege, Multidisciplinary Management Group, University Hospital Of Liège, Belgium, (3) Department Of Internal Medicine And Infectiology, Chu Liège, Belgium, (4) Department Of 01. Viral infection & disease (non CO- VID-19) 1d. Herpesviruses (incl. diagnostics & epidemiology, antiviral drugs, treat- ment & susceptibility/resistance, excl clinical studies in immunocompromised hosts) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13397&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2875 08. Healthcare-as- sociated infections, infection prevention & control 8e. Hospital epidemiology, transmis- sion, surveillance & screening (incl. environment) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13398&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0748 aly, (2) Teaching Hospital Sant’Andrea, Sapienza University Of Rome, Italy 03. Bacterial suscepti- bility & resistance 3b. Resistance surveillance & epidemio- logy: Gram-negatives https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13401&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0156 ance, (3) Laboratoire De Bactériologie, Hôpital Kremlin Bicêtre, Aphp, France 04. Diagnostic micro- biology 4h. Clinical metagenomics https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13404&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1844 03. Bacterial suscepti - bility & resistance 3b. Resistance surveillance & epidemio- logy: Gram-negatives https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13406&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=E1242https://online.eccmid.org/programme-live-1?coday=2023-04-18&openSession=EF256 ntre For Disease Prevention And Control (Ecdc), Sweden, (3) Centro De Vigilancia Sanitaria Veterinaria (Visavet), Universidad Complutense De Madrid, Spain 02. Bacterial infection & disease 2g. Zoonotic bacterial infections (incl. foodborne, waterborne and vector-bor- ne pathogens, veterinary microbiology and One Health aspects, excl. AMR) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13408&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1469 rsity, Korea, Republic Of 13. Case reports and case series (n<10) 13a. Viral infections https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13409&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P3163 05. New antibacte- rial agents, PK/PD & Stewardship 5b. Pharmacokinetics/pharmacody- namics of antibacterial drugs & thera- peutic drug monitoring https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13410&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2202 sulting Aps, Denmark 05. New antibacte- rial agents, PK/PD & Stewardship 5d. Antimicrobial stewardship and pre- scribing (incl. interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13411&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=E0221https://online.eccmid.org/programme-live-1?coday=2023-04-15&openSession=EF048 Loire, France 08. Healthcare-as- sociated infections, infection prevention & control 8b. Other foreign-body and implant-as- sociated infections (incl. PJI) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13412&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=E1179https://online.eccmid.org/programme-live-1?coday=2023-04-18&openSession=EF238 gna (1, 2), Marco Ripa (1, 2) - (1) San Raffaele Vita-Salute University, Italy, (2) Irccs San Raffaele Scientific Institute, Department Of Infectious Diseases, Italy, (3) Irccs San Raffaele Scientific Institute, Department Of Cardiac Electrophysiology, Italy 09. Experimental microbiology, micro- bial pathogenesis & biofilm 9b. Host-pathogen interaction (incl. ba- sic microbiome studies, animal models) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13414&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0992 03. Bacterial suscepti- bility & resistance 3d. Resistance mechanisms incl. in vitro and in vivo studies, mobile elements (excl. TB) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13415&preview=1&aig=-1https://online.eccmid.org/programme-live-1?coday=2023-04-17&openSession=OS158 d Hygiene And Control, Faculty Of Veterinary Medicine, South Valley University, Egypt, (3) Department Of Zoonoses, Faculty Of Veterinary Medicine, Zagazig University, Egypt, (4) Hôpital Fribourgeois-Hôpital Cantonal De Fribourg, Switzerland, (5) Switzerland National 03. Bacterial suscepti- bility & resistance 3c. Susceptibility testing methods (incl. assay validation, phenotypic assays and comparative studies, excl. TB) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13416&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0382 niversité Catholique De Louvain (Uclouvain), Belgium 06. Fungal infection & disease 6e. Basic mycology (incl. in vitro and in vivo studies, pathogenesis) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13417&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2084 dical University Of Graz, Division Of Gastroenterology And Hepatology, Austria, (4) Medical University Of Graz, Clinical Institute Of Medical And Chemical Laboratory Diagnostics, AustriaABSTRACTS4 Abstracts Nr & Co-authors Presentation Nr TitlePresenterDateTime Inter- vention LocationSession Code Session TypeSessionSession Time 2256P0650 Impact of the COVID-19 pandemic on the consumption of antibiotics in the European com- munity, a changepoint analysis Helene Ver- meulen 15-04-202312:00 Poster Area PS025 Poster Session 3h. Policy aspects of AMR incl. societal impact, economics, mitigation 12:00 Helene Vermeulen (1), Niel Hens (1, 2), Lucy Catteau (3), Boudewijn Catry (3, 4), Samuel Coenen (5) - (1) Interuniversity Institute For Biostatistics And Statistical Bioinformatics (I-Biostat), Data Science Institute (Dsi), Hasselt University, Belgium, (2) Centre For Health Economic Research And Modelling Infectious Diseases, Vaccine & Infectious Disease Institute (Vaxinfectio), University Of Antwerp, Belgium, (3) Department Of Epidemiology And Public Health, Sciensano, Belgium, (4) Faculty Of Medicine, Université Libre De Bruxel les (Ulb), Belgium, (5) Laboratory Of Medical Microbiology (Lmm), Vaccine & Infectious Disease Institute (Vaxinfectio), University Of Antwerp, Belgium 2257O0919 Community-acquiredStaphylococcus au- reusmeningitis in adults Thijs Van Soest17-04-202314:06Hall COS191 1-hour Oral Session New developments in bacterial CNS infections 13:30 Thijs Van Soest (1, 2, 3), Maria Birgitte Søndermølle (4, 3), Matthijs C. Brouwer (1, 2, 3), Nora Chekrouni (1, 2, 3), Anders Rhod Larsen (5), Andreas Petersen (5), Nina M. Van Sorge (6), Henrik Nielsen (4, 7), Diederik Van De Beek (1, 2, 3), Jacob Bodilsen (4, 3) - (1) Department Of Neurology, Amsterdam Umc, Location University Of Amsterdam, Netherlands, (2) Amsterdam Neurosciences, Neuroinfection And - Inflammation, Netherlands, (3) European Society For Clinical Microbiology And Infectious Disease (Escmid) Study Group On Infections Of The Brain (Esgib), (4) Department Of Infectious Diseases, Aalborg University Hospital, Denmark, (5) Statens Serum Institut, Denmark, (6) Department Of Medical Microbiology And Infection Prevention, Amsterdam Umc Location University Of Amsterdam, Amsterdam Infection And Immunity, Netherlands, (7) Netherlands Reference Laboratory For Bacterial Meningitis, Amsterdam Umc Location Amc, Netherlands 2260P2262 Cefiderocol use in monotherapy or combination therapy for the treatment of infections with carba- penem-resistant Gram-negative bacteria: an Italian multi-centre real-life experience Michele Spi- nicci 17-04-202312:00 Poster Area PS038 Poster Session 5c. New or repurposed antibac- terial agents: clinical studies and trials 12:00 Matteo Piccica (1), Michele Spinicci (1, 2), Annarita Botta (3), Vincenzo Bianco (3), Filippo Lagi (2), Lucia Graziani (1), Alessandro Faragona (4), Roberto Parrella (3), Tommaso Giani (1), Andrea Bartolini (1), Gian Maria Rossolini (1, 5), Marcello Tavio (6), Andrea Giacometti (4), Alessandro Bartoloni (1, 2) - (1) Department Of Experimental And Clinical Medicine, University Of Florence, Italy, (2) Infectious And Tropical Diseases Unit, Azienda Ospedaliero-Universitaria Careggi, Italy, (3) Department Of Infectious Disease And Infectious Emergencies, Aorn Dei Colli, Cotugno Hospital, Italy, (4) Clinic Of Infectious Diseases, Azienda Ospedaliero Universitaria, Ospedali Riuniti Umberto I-Lancisi-Salesi, Italy, (5) Clinical Microbiology And Virology Unit, Florence Careggi University Hospital, Italy, (6) Unit Of Emerging And Immunosuppressed Infectious Diseases, Department Of Gastroenterology And Transplantation, Azienda Ospedaliero-Universitaria „Ospedali Riuniti“, Italy 2263P2604 Evaluation of SARS-CoV-2 PCR test Ct values in correlation of virus and antigen amount, tested genetic target and virus strain Paul Naaber17-04-202312:00 Poster Area PS085 Poster Session 12d. Diagnostics (incl. molecular, genomic, rapid tests) 12:00 Kaspar Ratnik, Epp Sepp, Paul Naaber - (1) Synlab Eesti, Estonia 2264P1777 Whole genome sequencing of Streptococcus pyogenes to identify transmission events in cases with epidemiological links to neonates Hong Fang16-04-202312:00 Poster Area PS030 Poster Session 4e. Strain typing and surveillance (incl. molecular, genomic and other advanced methods) 12:00 Barasevich Katinka, Sambhu Ganeshappa Aralaguppe, Hong Fang - (1) Department Of Clinical Microbiology, Karolinska University Hospital, Karolinska Institutet, Sweden 2265P1856 On-plate colistin resistance detection in K. pneu- moniae by MALDI-TOF MS biomarker discovery Elena De Carolis 16-04-202312:00 Poster Area PS034 Poster Session 4i. Bioinformatics tools and pi- pelines 12:00 Elena De Carolis (1), Valentino Costabile (2), Gianluca Foglietta (2), Vincenzo Di Pilato (3), Gian Maria Rossolini (4), Maurizio Sanguinetti (1), Carlo Federico Perno (2), Paola Bernaschi (2) - (1) Fondazione Policlinico Universitario A. Gemelli, Irccs, Italy, (2) Ospedale Pediatrico Bambino Gesù - Irccs, Italy, (3) Università Di Genova, Italy, (4) Ospedale Careggi, Italy 2266P0226 Prevalence of carbapenemase-producing Entero- bacterales colonisation and risk factor of clinical infection Kyoung Hwa Lee 15-04-202312:00 Poster Area PS019 Poster Session 3b. Resistance surveillance and epidemiology: Gram-negatives 12:00 Kyoung Hwa Lee (1), Do Kyun Kim (2), Jun Sung Hong (2), Soon Young Park (1), Eun Hwa Lee (1), Sang Hoon Han (1), Seok Hoon Jeong (2), Young Goo Song (1) - (1) Division Of Infectious Diseases, Department Of Internal Medicine, Yonsei University College, Korea, Republic Of, (2) Department Of Laboratory Medicine, Yonsei University College Of Medicine, Korea, Republic Of 2267P2816 Performance of an HAV IgG rapid test from capil- lary whole-blood in Swiss opioid agonist therapy (OAT) patients Andrea Bre- genzer 17-04-202312:00 Poster Area PS002 Poster Session 1b. Viral hepatitis (incl. diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibili- ty/resistance) 12:00 Andrea Bregenzer (1), Stefanie Eichhorn (1), Petra Rippstein (2), Michael Oberle (3), Christoph Andreas Fux (1) - (1) Department Of Infectious Diseases And Infection Prevention, Cantonal Hospital Aarau, Switzerland, (2) Outpatient Centre Of Substitution Therapy Hag, Department Of Addictive Disorders, Psychiatric Services Aargau, Switzerland, (3) Institute For Laboratory Medicine, Cantonal Hospital Aarau, Switzerland 2268P2082 Iron regulatory pathways differentially expressed during Madurella mycetomatis grain development in Galleria mellonella Mickey Konings16-04-202312:00 Poster Area PS046 Poster Session 6e. Basic mycology (incl. in vitro and in vivo studies, pathogenesis) 12:00 Imad Abugessaisa (1), Mickey Konings (2), Ri-Ichiroh Manabe (1), Tsugumi Kawashima (1), Akira Hasegawa (1), Chitose Takahashi (1), Michihira Tagami (1), Yasushi Okazaki (1), Wilson Lim (2), Annelies Verbon (2, 3), Ahmed H. Fahal (4), Takeya Kasukawa (1), Wendy W. J. Van De Sande (2) - (1) Riken Center For Integrative Medical Sciences, Japan, (2) Erasmus Mc, Netherlands, (3) Umc Utrecht, Netherlands, (4) Mycetoma Research Center, Sudan 2270P0737 Vancomycin-resistant Enterococcus faecium clones are a moving target: using whole genome sequen- cing data to develop clone-specific PCRs Maja Johanne Søndergaard Knudsen 15-04-202312:00 Poster Area PS059 Poster Session 8e. Hospital epidemiology, trans- mission, surveillance & screening (incl. environment) 12:00 Maja Johanne Søndergaard Knudsen, Christel Barker Jensen, Ingrid Maria Cecilia Rubin, Sarah Mollerup, Peder Worning, Jose Alfredo Samaniego Castruita, Henrik Westh, Mette Pinholt - (1) Department Of Clinical Microbiology, Denmark 2271P2705 The immunological effects of COVID-19 vaccinati- on after past infection in lung transplant recipients Coretta Van Leer Buter 17-04-202312:00 Poster Area PS088 Poster Session 12g. Vaccine development, trials, efficacy, policy 12:00 Siqi Liu (1), Rogier Hoek (2), Erik Verschuuren (3), Judith Vonk (4), Debbie Van Baarle (5, 6), Rory De Vries (7), Corine Geurtsvankessel (7), Coretta Van Leer Buter (1) - (1) Dept Medical Microbiology, University Medical Center Groningen, Netherlands, (2) Dept. Of Pulmonary Medicine, University Medical Center Rotterdam, Netherlands, (3) Dept. Of Pulmonary Diseases, University Medical Center Groningen, Netherlands, (4) Dept. Of Epidemiology And Groningen Research Institute For Asthma And Copd (Griac), University Medi cal Center Groningen, Netherlands, (5) Dept. Of Medical Microbiology, University Medical Center Groningen, Netherlands, (6) Center For Infectious Disease Control, National Institute For Public Health And The Environment, Netherlands, (7) Dept. Of Viroscience, Erasmus Medical Center, Netherlands 2272P1314 Impact of prolonged azithromycin treatment on the microbiological pattern of acute exacerbations in chronic obstructive pulmonary disease Anna Carre- ra-Salinas 16-04-202312:00 Poster Area PS012 Poster Session 2c. Community-acquired respira- tory infections (incl. epidemiology, clinical, imaging, treatment & prevention) 12:00 Anna Carrera-Salinas (1), Ester Cuevas (2), Daniel Huertas (3), Concepción Montón (4), Alicia Marin (5, 6), Xavier Pomares (4), Marian García-Núñez (4, 5), Sara Marti (5, 1), Salud Santos (5, 2) - (1) Department Of Microbiology, Hospital Universitari Bellvitge. Idibell-Ub, Spain, (2) Department Of Respiratory Medicine, Hospital Universitari Bellvitge. Idibell-Ub, Spain, (3) Department Of Respiratory Medicine, Consorci Sanitari Alt Penedès Garraf, Spain, (4) Department Of Respiratory Medicine, Corporació Sanitària Parc Taulí, Spain, (5) Research Network For Respiratory Diseases (Ciberes), Isciii, Spain, (6) Department Of Respiratory Medicine, Hospital Germans Trias I Pujol, Spain 2273E0713 AmpC β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Southeast Asia Tamalee Ro- berts 16-04-202316:45Arena 1EF145 1-hour ePoster Flash Session AMR in LMICs16:15 Tamalee Roberts (1, 2), Clare Ling (3, 2), Wantida Watthanaworawit (4), Chanvoleak Cheav (3), Amphonesavanh Sengduangphachanh (1), Joy Silisouk (1), Jill Hopkins (3, 2), Paul Turner (3, 2), Elizabeth Ashley (1, 2) - (1) Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Lao People‘s Democratic Republic, (2) Centre For Tropical Medicine And Global Health, Nuffield Department Of Medicine, University Of Oxford, United Kingdom, (3) Cambodia Oxford Medical Research Unit, Cambodia, (4) Shoklo Malaria Rese arch Unit, Mahidol-Oxford Tropical Medicine Research Unit, Thailand 2274P1851 Optimised long read 16S metagenomics for clinical diagnostics Anna Fager- ström 16-04-202312:00 Poster Area PS033 Poster Session 4h. Clinical metagenomics12:00 Anna Fagerström (1), Lina Guerra Blomqvist (2), Frans Wallin (1), Dimitrios Arnellos (3), Marita Ekström (1), Martin Ekman (2), Martin Sundqvist (1), Martin Vondracek (2), Paula Mölling (1) - (1) Department Of Laboratory Medicine, Clinical Microbiology, Faculty Of Medicine And Health, Örebro University, Sweden, (2) Department Of Clinical Microbiology, Karolinska University Hospital, Sweden, (3) 2275P2385 Role of anesthesia providers in infection-related care in the perioperative pathway: results of a global survey Esmita Charani17-04-202312:00 Poster Area PS039 Poster Session 5d. Antimicrobial stewardship and prescribing(incl. interventions, monitoring, impact, decision-sup- port / prediction tools, behaviou- ral aspects) 12:00 Gabriel Birgand (1), Antoine Deslandes (2), Oluchi Mbamalu (3), Candice Bonaconsa (3), Bruce Biccard (3), Adam Boutall (3), Marc Mendelson (3), Jules Ndoli (4), Andrew Leather (5), Alison Holmes (1), Ramani Moonesinghe (6), Esmita Charani (3) - (1) Imperial College London, United Kingdom, (2) Nantes University Hospital, France, (3) University Of Cape Town, South Africa, (4) Butare University Teaching Hospital, Rwanda, (5) Kings College London, United Kingdom, (6) University College London, United Kingdom 2276P2595 Comparison of two commercial NGS SARS-CoV2 sequencing kits Laura Ver- durme 17-04-202312:00 Poster Area PS085 Poster Session 12d. Diagnostics (incl. molecular, genomic, rapid tests) 12:00 Laura Verdurme, Mathilde Roussel, Stephanie Haïm Boukobza, Benoît Visseaux, Sabine Trombert, Camille D‘Humières - (1) Cerba, France 2279O1209 SARS-CoV-2 Delta clades are associated with hig- her hospitalisation rates in unvaccinated but not in the vaccinated population Kristi Huik18-04-202311:24Hall COS250 1-hour Oral Session Clinical phenotypes in the era of evolving SARS-CoV-2 variants 11:00 Taavi Päll (1), Aare Abroi (1), Radko Avi (1), Heiki Niglas (2), Merit Pauskar (1), Arina Shablinskaja (1), Eveli Kallas (1), Ene-Ly Jõgeda (1), Andrio Lahesaare (3), Kai Truusalu (1), Dagmar Hoidmets (1), Liidia Dotsenko (2), Olga Sadikova (2), Kaspar Ratnik (3), Hanna Sepp (2), Jevgenia Epštein (2), Heleene Suija (2), Katrin Kaarna (1, 4), Steven Smit (1), Lili Milani (1), Mait Metspalu (1), Ott Eric Oopkaup (1), Ivar Koppel (1), Jaaniso Jaaniso (1), Ivan Kuzmin (1), Heleri Inno (1), Uku Raudvere (1), Paul Naaber (3, 1), Mari-Anne Härma (2), Tuuli Reisberg (1), Hedi Peterson (1), Ulvi Gerst Talas (1), Irja Lutsar (1), Kristi Huik (1) - (1) University Of Tartu, Estonia, (2) Estonian Health Board, Estonia, (3) Synlab Eesti Oü, Estonia, (4) Tartu University Hospital, EstoniaFINAL PROGRAMME – 33RD ECCMID Copenhagen, Denmark 2023 5 CategorySub-categoryLink AbstractsLink EposterLink Oral Session 03. Bacterial suscepti- bility & resistance 3h. Policy aspects of AMR incl. societal impact, economics, mitigation https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13418&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0650 Economic Research And Modelling Infectious Diseases, Vaccine & Infectious Disease Institute (Vaxinfectio), University Of Antwerp, Belgium, (3) Department Of Epidemiology And Public Health, Sciensano, Belgium, (4) Faculty Of Medicine, Université Libre De Bruxel- 02. Bacterial infection & disease 2f. Community acquired nervous sys- tem and other multi-system bacterial infections (incl. epidemiology, clinical, imaging, treatment & prevention) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13419&preview=1&aig=-1https://online.eccmid.org/programme-live-1?coday=2023-04-17&openSession=OS191 partment Of Neurology, Amsterdam Umc, Location University Of Amsterdam, Netherlands, (2) Amsterdam Neurosciences, Neuroinfection And - Inflammation, Netherlands, (3) European Society For Clinical Microbiology And Infectious Disease (Escmid) Study Group rdam, Amsterdam Infection And Immunity, Netherlands, (7) Netherlands Reference Laboratory For Bacterial Meningitis, Amsterdam Umc Location Amc, Netherlands 05. New antibacte- rial agents, PK/PD & Stewardship 5c. New or repurposed antibacterial agents: clinical studies and trials https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13422&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2262 metti (4), Alessandro Bartoloni (1, 2) - (1) Department Of Experimental And Clinical Medicine, University Of Florence, Italy, (2) Infectious And Tropical Diseases Unit, Azienda Ospedaliero-Universitaria Careggi, Italy, (3) Department Of Infectious Disease And Infectious Emerging And Immunosuppressed Infectious Diseases, Department Of Gastroenterology And Transplantation, Azienda Ospedaliero-Universitaria „Ospedali Riuniti“, Italy 12. COVID-19 12d. Diagnostics (incl. molecular, geno- mic, rapid tests) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13425&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2604 04. Diagnostic micro- biology 4e. Strain typing and surveillance (incl. molecular, genomic and other advan- ced methods) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13426&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1777 04. Diagnostic micro- biology 4i. Bioinformatics tools & pipelines https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13427&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1856 diatrico Bambino Gesù - Irccs, Italy, (3) Università Di Genova, Italy, (4) Ospedale Careggi, Italy 03. Bacterial suscepti- bility & resistance 3b. Resistance surveillance & epidemio- logy: Gram-negatives https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13428&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0226 epublic Of, (2) Department Of Laboratory Medicine, Yonsei University College Of Medicine, Korea, Republic Of 01. Viral infection & disease (non CO - VID-19) 1b. Viral hepatitis (incl. diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13429&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2816 ag, Department Of Addictive Disorders, Psychiatric Services Aargau, Switzerland, (3) Institute For Laboratory Medicine, Cantonal Hospital Aarau, Switzerland 06. Fungal infection & disease 6e. Basic mycology (incl. in vitro and in vivo studies, pathogenesis) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13430&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2082 W. J. Van De Sande (2) - (1) Riken Center For Integrative Medical Sciences, Japan, (2) Erasmus Mc, Netherlands, (3) Umc Utrecht, Netherlands, (4) Mycetoma Research Center, Sudan 08. Healthcare-as- sociated infections, infection prevention & control 8e. Hospital epidemiology, transmis- sion, surveillance & screening (incl. environment) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13432&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0737 12. COVID-19 12g. Vaccine development, trials, efficacy, policy https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13433&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2705 lmonary Medicine, University Medical Center Rotterdam, Netherlands, (3) Dept. Of Pulmonary Diseases, University Medical Center Groningen, Netherlands, (4) Dept. Of Epidemiology And Groningen Research Institute For Asthma And Copd (Griac), University Medi- asmus Medical Center, Netherlands 02. Bacterial infection & disease 2c. Community-acquired respiratory infections (incl. epidemiology, clinical, imaging, treatment & prevention) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13434&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1314 Ub, Spain, (2) Department Of Respiratory Medicine, Hospital Universitari Bellvitge. Idibell-Ub, Spain, (3) Department Of Respiratory Medicine, Consorci Sanitari Alt Penedès Garraf, Spain, (4) Department Of Respiratory Medicine, Corporació Sanitària Parc Taulí, Spain, 03. Bacterial suscepti- bility & resistance 3b. Resistance surveillance & epidemio- logy: Gram-negatives https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13435&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=E0713https://online.eccmid.org/programme-live-1?coday=2023-04-16&openSession=EF145 Research Unit, Lao People‘s Democratic Republic, (2) Centre For Tropical Medicine And Global Health, Nuffield Department Of Medicine, University Of Oxford, United Kingdom, (3) Cambodia Oxford Medical Research Unit, Cambodia, (4) Shoklo Malaria Rese- 04. Diagnostic micro- biology 4h. Clinical metagenomics https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13436&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1851 Medicine And Health, Örebro University, Sweden, (2) Department Of Clinical Microbiology, Karolinska University Hospital, Sweden, (3) 1928 Diagnostics, Sweden 05. New antibacte- rial agents, PK/PD & Stewardship 5d. Antimicrobial stewardship and pre- scribing (incl. interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13437&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2385 ege London, United Kingdom, (2) Nantes University Hospital, France, (3) University Of Cape Town, South Africa, (4) Butare University Teaching Hospital, Rwanda, (5) Kings College London, United Kingdom, (6) University College London, United Kingdom 12. COVID-19 12d. Diagnostics (incl. molecular, geno- mic, rapid tests) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13438&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2595 12. COVID-19 12l. Virus evolution, variant detection and analysis, impact https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13441&preview=1&aig=-1https://online.eccmid.org/programme-live-1?coday=2023-04-18&openSession=OS250 (2), Jevgenia Epštein (2), Heleene Suija (2), Katrin Kaarna (1, 4), Steven Smit (1), Lili Milani (1), Mait Metspalu (1), Ott Eric Oopkaup (1), Ivar Koppel (1), Jaaniso Jaaniso (1), Ivan Kuzmin (1), Heleri Inno (1), Uku Raudvere (1), Paul Naaber (3, 1), Mari-Anne Härma (2), ABSTRACTS6 Abstracts Nr & Co-authors Presentation Nr TitlePresenterDateTime Inter- vention LocationSession Code Session TypeSessionSession Time 2280P0541 Potential use of Raman spectroscopy for detection of antimicrobial resistance Katarina Rebro- sova 15-04-202312:00 Poster Area PS022 Poster Session 3e. Resistance detection / pre- diction approaches (rapid and/ or molecular assays, resistome analysis, inference methods) 12:00 Katarina Rebrosova (1), Martin Siler (2), Ota Samek (2), Jan Jezek (2), Veronika Hola (1), Filip Ruzicka (1) - (1) Department Of Microbiology, Faculty Of Medicine And St. Anne’S University Hospital, Czech Republic, (2) Institute Of Scientific Instruments, Czech Academy Of Sciences, Czech Republic 2281O0935 Clonal fungemia outbreak of L. elongisporus in neonatal intensive care unit in Delhi and loss of heterozygosity, an adaptive strategy in the en- vironmental L. elongisporus Anamika Yadav17-04-202314:18Hall POS194 1-hour Oral Session Impact of host and pathogen genetics in fungal infections 13:30 Anamika Yadav (1, 2), Peeyush Jain (3), Yue Wang (4), Kusum Jain (1, 2), Aditi Singh (3), Ashutosh Singh (2), Jianping Xu (5), Anuradha Chowdhary (2) - (1) Zoology Dept., Ramjas College, University Of Delhi, India, (2) Medical Mycology Unit, Department Of Microbiology, Vallabhbhai Patel Chest Institute, University Of Delhi, India, (3) Department Of Paediatrics, Hindu Rao Hospital And Ndmc Medical College, India, (4) Department Of Biology, Mcmaster University, Canada, (5) Department Of Biology, Mcmaster University, Hamil ton, Canada 2282P1904 Baseline risk factors for mortality in Candidaemia: the role of Candida tropicalis and rare Candida species Matthias Egger16-04-202312:00 Poster Area PS042 Poster Session 6a. Fungal disease epidemiology12:00 Matthias Egger (1, 2), Jon Salmanton-García (3), Philipp Koehler (3), Jean-Pierre Gangneaux (4), Maiken C. Arendrup (5), Aleksandra Barac (6), Arikan-Akdagli Sevtap (7), Matteo Bassetti (8), Oliver A. Cornely (3), Martin Hönigl (1) - (1) Medical University Of Graz, Division Of Infectious Diseases, Austria, (2) Biotechmed, Austria, (3) University Of Cologne, Faculty Of Medicine And University Hospital Cologne, Department I Of Internal Medicine, Germany, (4) University Of Rennes, France, (5) University Of Copenhagen, Departmen Of Clinical Microbiology, Denmark, (6) University Of Belgrade, Clinical For Infectious And Tropical Diseases, Serbia, (7) Hacettepe University, Turkey, (8) University Of Genoa, Infectious Diseases Unit, Italy 2284P1434 Otitis in patients with community-acquired bacte- rial meningitis: patients characteristics and role of the surgery Martina Ran- zenigo 16-04-202312:00 Poster Area PS015 Poster Session 2f. Community acquired nervous system and other multi-system bacterial infections(incl. epide- miology, clinical, imaging, treat- ment & prevention) 12:00 Martina Ranzenigo (1, 2, 3), Thijs M. Van Soest (1), Erik F. Hensen (4), Paola Cinque (2), Antonella Castagna (2, 3), Matthijs C. Brouwer (1), Diederik Van De Beek (1) - (1) Amsterdam Umc, Location University Of Amsterdam, Department Of Neurology, Meibergdreef, Netherlands, (2) Irccs San Raffaele Scientific Institute, Department Of Infectious Diseases, Italy, (3) Vita-Salute San Raffaele University, Italy, (4) Leiden University Medical Center, Department Of Otorhinolaryngology And Head And Neck Surgery, Netherlands 2285P2548 Different clinical presentations of post COVID-19 conditions between vaccinated and unvaccinated children after SARS-CoV-2 Omicron variant infecti- on in Taiwan Yu-Lung Hsu17-04-202312:00 Poster Area PS084 Poster Session 12c. Clinical features, case ma- nagement, complications, outco- me (incl. long-term) 12:00 Yu-Lung Hsu (1), Hsiao-Chuan Lin (1), Huan-Cheng Lai (1), Chien-Heng Lin (2), Chieh-Ho Chen (2), Hsiu-Mei Wei (1), An-Chyi Chen (3), Hung-Chih Lin (4), I-Ching Chou (5), Wen-Jue Soong (2), Kao-Pin Hwang (1), Kai-Sheng Hsieh (6), Jiu-Yao Wang (7) - (1) Pediatric Infectious Diseases, China Medical University Children’S Hospital, China Medical University, Taiwan, Republic Of China, (2) Pediatric Pulmonology, China Medical University Children’S Hospital, China Medical University, Taiwan, Republic Of China, (3) Pediatric Gast roenterology, China Medical University Children’S Hospital, China Medical University, Taiwan, Republic Of China, (4) Neonatology, China Medical University Children’S Hospital, China Medical University, Taiwan, Republic Of China, (5) Pediatric Neurology, China Medical University Children’S Hospital, China Medical University, Taiwan, Republic Of China, (6) Pediatric Cardiology, China Medical University Children‘S Hospital, China Medical University, Taiwan, Republic Of China, (7) Center For Allergy, Immunology, And Microbiome (A.I.M.), China Medical University Hospital, China Medical University Children’S Hospital, China Medical University, Taiwan, Republic Of China 2286P2269 The effect of probenecid on phenoxymethylpeni- cillin pharmacokinetics/pharmacodynamics: a randomised, open-label, crossover trial Richard Wilson17-04-202312:00 Poster Area PS038 Poster Session 5c. New or repurposed antibac- terial agents: clinical studies and trials 12:00 Richard Wilson (1, 2, 3), Alaa Riezk (2), Paul Arkell (2), Damien Ming (2), Mark Gilchrist (3, 2), Anne-Grete Märtson (1), William Hope (1), Alison Holmes (1, 2), Timothy Rawson (2) - (1) Antimicrobial Pharmacodynamics And Therapeutics, Department Of Pharmacology, University Of Liverpool, United Kingdom, (2) Centre For Antimicrobial Optimisation, Imperial College London, United Kingdom, (3) Imperial College Healthcare Nhs Trust, United Kingdom 2287P0205 Genomic epidemiology of Neisseria gonorrhoeae and emergence of a strain harbouring TEM-type ESBL in Stockholm, Sweden Nora Vestberg15-04-202312:00 Poster Area PS019 Poster Session 3b. Resistance surveillance and epidemiology: Gram-negatives 12:00 Nora Vestberg, Karin Haij Bhattarai, Hong Fang - (1) Department Of Clinical Microbiology, Karolinska University Hospital, Sweden 2288P2672 Evaluation of humoral response to vaccine and infection by SARS-CoV-2 in health care workers: a longitudinal study Rui Figueiredo17-04-202312:00 Poster Area PS087 Poster Session 12f. Immune response and modu- lation (incl. immunity and respon- se measurement, immunomodula- tion, antibody treatment) 12:00 Carlos Cortes, Rui Figueiredo, Luís Morais, Sandra Paredes, Ana Augusto, Paula Gama - (1) Centro Hospitalar Médio Tejo, Portugal 2290P0840 Examining the response to an outbreak of carba- penemase-producing Enterobacteriaceae in a neonatal intensive care unit in the UK: an outbreak report Megha Anil15-04-202312:00 Poster Area PS060 Poster Session 8f. Other healthcare associated infections (incl. CDI, hospital outbreaks) 12:00 Megha Anil (1), Jacki Dopran (2), Alleyna Claxton (3), Paul Fleming (4, 5), Narendra Aladangady (4, 5) - (1) Department Of Public Health, Tower Hamlets, Barts Health Nhs Trust, United Kingdom, (2) Herts & West Essex Lmns, Previously Homerton Healthcare Nhs Foundation Trust, United Kingdom, (3) Department Of Infection, Homerton Healthcare Nhs Foundation Trust, United Kingdom, (4) Neonatal Unit, Homerton Healthcare Nhs Foundation Trust, United Kingdom, (5) Center For Paediatrics, Barts And The London School Of Medicine And Dentistry, Qmul, United Kingdom 2293P2248 Free fraction variability of beta-lactam antimicro- bials in adult critically ill patients: a systematic review Thomas De Corte 17-04-202312:00 Poster Area PS037 Poster Session 5b. Pharmacokinetics/pharma- codynamics of antibacterial drugs & therapeutic drug monitoring 12:00 Dirk Haak (1), Thomas De Corte (1, 2), Veronique Stove (3), Jan J De Waele (1, 2) - (1) Department Of Internal Medicine And Pediatrics, Faculty Of Medicine And Health Sciences, Ghent University, Belgium, (2) Department Of Intensive Care Medicine, Ghent University Hospital, Belgium, (3) Department Of Diagnostic Sciences, Faculty Of Medicine And Health Sciences, Ghent University, Belgium 2294P2697 Humoral and cellular immune responses to the COVID-19 vaccination in lung transplantation recipients Coretta Van Leer Buter 17-04-202312:00 Poster Area PS088 Poster Session 12g. Vaccine development, trials, efficacy, policy 12:00 Rogier Hoek (1), Siqi Liu (2), Erik Verschuuren (3), Judith Vonk (4), Debbie Baarle (5, 6), Rory De Vries (7), Corine Geurtsvankessel (7), Coretta Van Leer Buter (2) - (1) Dept. Of Pulmonary Medicine, Erasmus Medical Center, Netherlands, (2) Dept. Of Medical Microbiology, University Medical Center Groningen, Netherlands, (3) Dept. Of Pulmonary Diseases, University Medical Center Groningen, Netherlands, (4) Dept. Of Epidemiology And Groningen Research Institute For Asthma And Copd (Griac),University Medical Center Groningen, Netherlands, (5) Dept. Of Medical Microbiology,University Medical Center Groningen, Netherlands, (6) Center For Infectious Disease Control, National Institute For Public Health And The Environment, Netherlands, (7) Dept. Of Viroscience, Erasmus Medical Center, Netherlands 2295P2937 JC virus detection in nasopharyngeal samples from Portuguese children: a clue to respiratory transmission Joana Oliveira17-04-202312:00 Poster Area PS007 Poster Session 1g. Viral epidemiology – general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV) 12:00 Joana Oliveira (1), Cristina Luxo (2), Ana Miguel Matos (3) - (1) Faculty Of Pharmacy, University Of Colimbra, Portugal, (2) Chemical Process Engineering And Forest Products Research Centre (Ciepqf), Faculty Of Pharmacy, University Of Coimbra, Portugal, (3) Chemical Process Engineering And Forest Products Research Centre (Ciepqf), Faculty Of Pharmacy, University Of Coimbra; Laboratory Of Clinical Analysis From University Of Coimbra, Portugal 2296P0896 Fecal microbiota transplantation: evaluation of microbial loads in human stool suspensions after freezing Andrea Roc- chetti 15-04-202312:00 Poster Area PS061 Poster Session 8g. Infection control interventions and trials (incl. microbiota trans- plantation) 12:00 Daria Vay (1), Matilde Gatto (2), Fabio Rapallo (3), Christian Leli (1), Antonio Maconi (4), Andrea Rocchetti (1) - (1) Department Of Microbiology, “Ss. Antonio E Biagio E Cesare Arrigo” Hospital, Italy, (2) University Of Eastern Piedmont, Department Of Science And Technological Innovation (Disit), Italy, (3) Department Of Economics, University Of Genova, Italy, (4) Research Training Innovation Infrastructure - Department Of Research And Innovation - Azienda, Ospedaliera Ss Antonio E Biagio E Cesare Arrigo, Italy 2297P1437 Diagnostic accuracy of granulocyte percentage in cerebrospinal fluid of adults with suspected central nervous system infection Steven Staal16-04-202312:00 Poster Area PS015 Poster Session 2f. Community acquired nervous system and other multi-system bacterial infections(incl. epide- miology, clinical, imaging, treat- ment & prevention) 12:00 Steven Staal, Sabine Olie, Liora Ter Horst, Ingeborg Van Zeggeren, Diederik Van De Beek, Matthijs Brouwer - (1) Amsterdam Umc, University Of Amsterdam, Department Of Neurology, Netherlands 2298P2686 Cellular responses to BNT162b2 vaccination by an interferon-gamma release assay: a prospective longitudinal study in healthcare workers Rui Figueiredo17-04-202312:00 Poster Area PS087 Poster Session 12f. Immune response and modu- lation (incl. immunity and respon- se measurement, immunomodula- tion, antibody treatment) 12:00 Carlos Cortes, Rui Figueiredo, Luís Morais, Sandra Paredes, Ana Augusto, Paula Gama - (1) Centro Hospitalar Médio Tejo, PortugalFINAL PROGRAMME – 33RD ECCMID Copenhagen, Denmark 2023 7 CategorySub-categoryLink AbstractsLink EposterLink Oral Session 03. Bacterial suscepti- bility & resistance 3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13442&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0541 y Of Sciences, Czech Republic 06. Fungal infection & disease 6c. Antifungal susceptibility testing & resistance (incl. surveillance) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13443&preview=1&aig=-1https://online.eccmid.org/programme-live-1?coday=2023-04-17&openSession=OS194 logy, Vallabhbhai Patel Chest Institute, University Of Delhi, India, (3) Department Of Paediatrics, Hindu Rao Hospital And Ndmc Medical College, India, (4) Department Of Biology, Mcmaster University, Canada, (5) Department Of Biology, Mcmaster University, Hamil- 06. Fungal infection & disease 6a. Fungal disease epidemiology https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13444&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1904 ision Of Infectious Diseases, Austria, (2) Biotechmed, Austria, (3) University Of Cologne, Faculty Of Medicine And University Hospital Cologne, Department I Of Internal Medicine, Germany, (4) University Of Rennes, France, (5) University Of Copenhagen, Departmen 02. Bacterial infection & disease 2f. Community acquired nervous sys- tem and other multi-system bacterial infections (incl. epidemiology, clinical, imaging, treatment & prevention) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13446&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1434 Netherlands, (2) Irccs San Raffaele Scientific Institute, Department Of Infectious Diseases, Italy, (3) Vita-Salute San Raffaele University, Italy, (4) Leiden University Medical Center, Department Of Otorhinolaryngology And Head And Neck Surgery, Netherlands 12. COVID-19 12c. Clinical features, case manage- ment, complications, outcome (incl. long-term) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13447&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2548 ectious Diseases, China Medical University Children’S Hospital, China Medical University, Taiwan, Republic Of China, (2) Pediatric Pulmonology, China Medical University Children’S Hospital, China Medical University, Taiwan, Republic Of China, (3) Pediatric Gast- cal University Children’S Hospital, China Medical University, Taiwan, Republic Of China, (6) Pediatric Cardiology, China Medical University Children‘S Hospital, China Medical University, Taiwan, Republic Of China, (7) Center For Allergy, Immunology, And Microbiome 05. New antibacte- rial agents, PK/PD & Stewardship 5c. New or repurposed antibacterial agents: clinical studies and trials https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13448&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2269 gy, University Of Liverpool, United Kingdom, (2) Centre For Antimicrobial Optimisation, Imperial College London, United Kingdom, (3) Imperial College Healthcare Nhs Trust, United Kingdom 03. Bacterial suscepti- bility & resistance 3b. Resistance surveillance & epidemio- logy: Gram-negatives https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13449&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0205 12. COVID-19 12f. Immune response and modulation (incl. immunity and response measu- rement, immunomodulation, antibody treatment) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13450&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2672 08. Healthcare-as- sociated infections, infection prevention & control 8f. Other healthcare associated infec- tions (incl. CDI, hospital outbreaks) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13452&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0840 undation Trust, United Kingdom, (3) Department Of Infection, Homerton Healthcare Nhs Foundation Trust, United Kingdom, (4) Neonatal Unit, Homerton Healthcare Nhs Foundation Trust, United Kingdom, (5) Center For Paediatrics, Barts And The London School Of 05. New antibacte- rial agents, PK/PD & Stewardship 5b. Pharmacokinetics/pharmacody- namics of antibacterial drugs & thera- peutic drug monitoring https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13455&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2248 ty Hospital, Belgium, (3) Department Of Diagnostic Sciences, Faculty Of Medicine And Health Sciences, Ghent University, Belgium 12. COVID-19 12g. Vaccine development, trials, efficacy, policy https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13456&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2697 logy, University Medical Center Groningen, Netherlands, (3) Dept. Of Pulmonary Diseases, University Medical Center Groningen, Netherlands, (4) Dept. Of Epidemiology And Groningen Research Institute For Asthma And Copd (Griac),University Medical Center ical Center, Netherlands 01. Viral infection & disease (non CO- VID-19) 1g. Viral epidemiology – general, preva- lence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13457&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2937 al Process Engineering And Forest Products Research Centre (Ciepqf), Faculty Of Pharmacy, University Of Coimbra; Laboratory Of Clinical Analysis From University Of Coimbra, Portugal 08. Healthcare-as- sociated infections, infection prevention & control 8g. Infection control interventions and trials (incl. microbiota transplantation) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13458&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0896 chnological Innovation (Disit), Italy, (3) Department Of Economics, University Of Genova, Italy, (4) Research Training Innovation Infrastructure - Department Of Research And Innovation - Azienda, Ospedaliera Ss Antonio E Biagio E Cesare Arrigo, Italy 02. Bacterial infection & disease 2f. Community acquired nervous sys- tem and other multi-system bacterial infections (incl. epidemiology, clinical, imaging, treatment & prevention) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13459&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1437 12. COVID-19 12f. Immune response and modulation (incl. immunity and response measu- rement, immunomodulation, antibody treatment) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13460&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2686ABSTRACTS8 Abstracts Nr & Co-authors Presentation Nr TitlePresenterDateTime Inter- vention LocationSession Code Session TypeSessionSession Time 2299P2826 Seroprevalence of hepatitis Delta virus and follow up of infected patients in a tertiary hospital Paloma Liendo Arenzana 17-04-202312:00 Poster Area PS002 Poster Session 1b. Viral hepatitis (incl. diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibili- ty/resistance) 12:00 Paloma Liendo Arenzana (1, 2), Mikel Urrutikoetxea-Gutierrez (1, 2), Estibaliz Ugalde Zarraga (1, 2), M. Carmen Nieto Toboso (1, 2), Belen Santos Montejo (1), Irene Fernández Brochado (1), Idoia Lázaro Gorriti (1), José Luis Diaz De Tuesta Del Arco (1, 2) - (1) Hospital Universitario Basurto, Spain, (2) Biocruces-Bizkaia Health Institute, Spain 2300P0937 Phenotypic and genotypic study of biofilm forma- tion ofPseudomonas aeruginosa strains isolated from patients with severe SARS-CoV-2 pneumonia Ohiana Rodri- guez Medina 15-04-202312:00 Poster Area PS064 Poster Session 9a. Microbial pathogenesis and virulence 12:00 Ohiana Rodriguez Medina (1), Marina Fernández Torres (2), Rodrigo Alonso Monsalve (1), Helena Barrasa Gonzalez (3), Andrés Canut Blasco (2), Ilargi Martinez Ballesteros (1), Irati Martinez Malaxetxebarria (1) - (1) Mikroiker Research Group, Department Of Immunology, Microbiology And Parasitology, Faculty Of Pharmacy, University Of The Basque Country Upv/Ehu, Spain, (2) Bioaraba, Clinical Microbiology, Vitoria-Gasteiz, Spain; Osakidetza, Basque Health Service, University Hospital Of Alava, Microbiology Service, Intensive Care Unit, University Hospital Of Alava, Basque Country, Spain, (3) Intensive Care Unit, Hospital Universitario De Álava, Spain 2301O0260 Characterising bacterial growth and killing kinetics of RG6006 usingin vitroand in vivotime-kill stu- dies and mechanism-based PK/PD modeling Chenyan Zhao15-04-202315:21Hall IOS059 1-hour Oral Session Innovative preclinical PK/PD studies 14:45 Chenyan Zhao (1), Caterina Bissantz (2), Valerie Cosson (2), Andrej Trauner (3), Claudia Zampaloni (3), Elisabet I Nielsen (1) - (1) Department Of Pharmacy, Uppsala University, Sweden, (2) Roche Pharma Research And Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Switzerland, (3) Roche Pharma Research And Early Development, Immunology, Infectious Disease And Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Switzerland 2302P2207 Effectiveness, safety and probability of PK/PD target achievement of ceftazidime/avibactam and ceftolozane/tazobactam vscolistin-based regimens in the treatment of hospital-acquired pneumonia caused by extensively-drug resistantPseudomonas aeruginosa Sonia Luque17-04-202312:00 Poster Area PS037 Poster Session 5b. Pharmacokinetics/pharma- codynamics of antibacterial drugs & therapeutic drug monitoring 12:00 Luisa Sorli (1), Sonia Luque (1), Laura Rio (1), Xenia Fernández (1), M Eugenia Navarrete (1), Adela Benítez-Cano (1), Joan Gómez-Junyent (1), Silvia Gómez-Zorrilla (1), Ivan Pelegrín (1), Judith Poblet (1), Jesus Alonso-Carrillo (2), Inmaculada López-Montesinos (1), Milagro Montero (1), Santiago Grau (1), Juan Pablo Horcajada (1) - (1) Hospital Del Mar, Spain, (2) Hospital 12 De Octubre, Spain 2303P1424 Diagnostic accuracy of inflammatory markers in cerebrospinal fluid and plasma of adults with suspected central nervous system infection Sabine Eva Olie16-04-202312:00 Poster Area PS015 Poster Session 2f. Community acquired nervous system and other multi-system bacterial infections(incl. epide- miology, clinical, imaging, treat- ment & prevention) 12:00 Sabine Eva Olie, Steven Staal, Liora Ter Horst, Ingeborg Van Zeggeren, Wing Man, Diederik Van De Beek, Matthijs Brouwer - (1) Amsterdam Umc, University Of Amsterdam, Department Of Neurology, Netherlands 2304P1379 Impact of COVID-19 restrictions on acute gastroen- teritis in children: a regional Danish register-based study Kumanan Nanthan 16-04-202312:00 Poster Area PS013 Poster Session 2d. Community-acquired abdo- minal/gastrointestinal, urinary tract & genital infections (incl. epidemiology, clinical, imaging, treatment & prevention) 12:00 Kumanan Nanthan (1), Eva Plantener (1), Andreas Pedersen (2), Mads Damkjær (3, 4), Ea Marmolin (1), Lotte Hansen (3), Jens Petersen (3), Roberto Pinilla (3), John Coia (1), Zhijun Song (1), Donna Wolff (2), Ming Chen (1) - (1) Department Of Clinical Microbiology, University Hospital Of Southern Denmark, Denmark, (2) Department Of Clinical Research, University Hospital Of Southern Denmark, Denmark, (3) Department Of Paediatrics, University Hospital Of Southern Denmark, Denmark, (4) Department Of Regional Health Research, University Of Southern Denmark, Denmark 2305P0142 OXA-48-producing Klebsiella pneumoniae from long-term colonisation: virulome and molecular epidemiology Manuel A. Rodríguez-Ig- lesias 15-04-202312:00 Poster Area PS019 Poster Session 3b. Resistance surveillance and epidemiology: Gram-negatives 12:00 Salud Rodriguez-Pallares, Alejandra Mateo-Vargas, Manuel A. Rodríguez-Iglesias, Fátima Galán-Sánchez - (1) Hospital Universitario Puerta Del Mar, Spain 2306P2580 Exhaled breath fingerprint differentiates COVID-19 from other respiratory infections Patricia Esteban Sánchez 17-04-202312:00 Poster Area PS085 Poster Session 12d. Diagnostics (incl. molecular, genomic, rapid tests) 12:00 Patricia Esteban Sánchez (1, 2), Santiago Letona (3), M. Pilar Domingo (2), Elena Morte (3), Galadriel Pellejero (3), Maria Del Mar Encabo (4), Rebeca Sanz (1, 5), Julián Pardo (1, 6, 7), José Ramón Paño (1, 3, 6), Eva M. Gálvez (2, 6) - (1) Fundación Instituto De Investigación Sanitaria Aragón (Iis Aragón), Biomedical Research Centre Of Aragón (Ciba), Spain, (2) Instituto De Carboquímica Icb-Csic, Spain, (3) Servicio De Enfermedades Infecciosas, Hospital Clínico Universitario Lozano Blesa, Spain, (4) Biobank Of The Aragon Health System, Iacs, Spain, (5) Ciberesp, Isciii - Ciber De Epidemiologia Y Salud Pública, Instituto De Salud Carlos Iii, Spain, (6) Ciberinfec, Isciii - Ciber De Enfermedades Infecciosas, Instituto De Salud Carlos Iii, Spain, (7) Departamento De Microbiología, Pediatría, Radiología Y Salud Pública, Área De Inmunología, Facultad De Medicina, Universidad De Zaragoza, Spain 2307O1142 Nanobody-based immunotherapy for the treat- ment of invasive fungal infections Elena Dola- der-Ballesteros 18-04-20239:54Hall OOS233 2-hour Oral Session New weapons against fungi: from clinical trials to innovative therapies 8:30 Sergio Redrado (1), Elena Dolader-Ballesteros (2), Javier Macías (3), María Pilar Domingo (1), Patricia Esteban (4, 1), Maykel Arias (1, 5), Ariel Ramírez (4, 5), Ramón Hurtado (3), Julián Pardo (2, 4, 5), Eva María Gálvez (1, 5) - (1) Instituto De Carboquímica Icb-Csic, Spain, (2) Departamento De Microbiología, Pediatría, Radiología Y Salud Pública, Área De Inmunología, Facultad De Medicina, Universidad De Zaragoza, Spain, (3) Instituto De Biocomputación Y Física De Sistemas Complejos (Bifi), Universidad De Zaragoza, Spain, (4) Fundación Instituto De Investigación Sanitaria Aragón (Iis Aragón), Centro De Investigación Biomédica De Aragón (Ciba), Spain, (5) Centro De Investigación Biomédica En Red En Enfermedades Infecciosas (Ciberinfec), Instituto De Salud Carlos Iii (Isciii), Spain 2310E0220 A living systematic review on antibiotic drug shor- tages and their impact on infection management Avaneesh Ku- mar Pandey 15-04-202313:42Arena 2EF048 1-hour ePoster Flash Session Antibiotic stewardship: anything you always wanted to know 13:30 Esmita Charani (1), Avaneesh Kumar Pandey (2), Amrita Ghataure (3), Nanda Gamad (2), Vrinda Nampoothiri (4), Oluchi Mbamalu (1), Jennifer Cohn (5), Alison Holmes (3), Sanjeev Singh (4), Marc Mendelson (1), Nusrat Shafiq (2) - (1) University Of Cape Town, South Africa, (2) Pgimer, India, (3) Imperial College London, United Kingdom, (4) Amrita Hospital, India, (5) Gardp, Switzerland 2311P1459 Dissection and potential association of Klebsiella pneumoniae of the emerging high-risk clones ST307 and ST147 from retail meat and human clinical origin Isidro Gar- cía-Meniño 16-04-202312:00 Poster Area PS016 Poster Session 2g. Zoonotic bacterial infections (incl. foodborne, waterborne and vector-borne pathogens, veteri- nary microbiology and One Health aspects, excl. AMR) 12:00 Isidro García-Meniño (1), Pilar Lumbreras (2), Javier Fernández (2), Azucena Mora (3), Jens André Hammerl (4) - (1) University Of Santiago De Compostela (Usc) . German Federal Institute For Risk Assessment (Bfr), Germany, (2) Instituto De Investigación Sanitaria Del Principado De Asturias (Ispa) . Hospital Universitario Central De Asturias (Huca), Spain, (3) University Of Santiago De Compostela (Usc), Spain, (4) German Federal Institute For Risk Assessment (Bfr), Germany 2312P0633 Screening and characterisation of multidrug-re- sistant Escherichia coli among bivalve samples of the Portuguese coast Marta Aires- De-Sousa 15-04-202312:00 Poster Area PS024 Poster Session 3g. Spread of resistance incl. car- riage, reservoirs, ecology, models (excl. nosocomial transmission) 12:00 Samanta Freire (1), Teresa Grilo (1), Bruna Rodrigues (1), Rui Oliveira (2), Carla Esteves (2), António Marques (2), Laurent Poirel (3), Marta Aires-De-Sousa (4) - (1) Laboratory Of Molecular Biology, Portuguese Red Cross, Portugal, (2) Instituto Português Do Mar E Atmosfera, Portugal, (3) Université De Fribourg, Switzerland, (4) Escola Superior De Saúde Da Cruz Vermelha Portuguesa-Lisboa, Portugal 2313P0601 Invasive non-typhoidal Salmonella infections: a regional UK-based retrospective narrative cohort analysis David Hettle15-04-202312:00 Poster Area PS024 Poster Session 3g. Spread of resistance incl. car- riage, reservoirs, ecology, models (excl. nosocomial transmission) 12:00 David Hettle (1), Mark Holloway (1), Hannah Pymont (2), Shuchita Soni (1), Michael Wilson (3), Irasha Harding (4) - (1) University Hospitals Bristol And Weston Nhs Trust, United Kingdom, (2) United Kingdom Health Security Agency South-West Regional Laboratory, United Kingdom, (3) North Bristol Nhs Trust, United Kingdom, (4) United Kingdom Health Security Agency, United Kingdom 2314O0445 Serotype distribution of non-invasive Streptococ- cus pneumoniae strains in Belgium, 2020-2022: a prospective, observational study Pieter-Jan Ceyssens 16-04-20239:30Hall POS086 2-hour Oral Session New trends in staphylococcal infections 8:30 Ioannis Passaris (1), Alexandra Vodolazkaia (1), Marina Mukovnikova (1), Chloé Abels (2), Pieter-Jan Ceyssens (1) - (1) Sciensano, Belgium, (2) Msd Belgium, Belgium 2315P1712 Enhancing pathogen identification in hospitalised patients with suspected meningitis using molecu- lar methods at a tertiary hospital in South Africa Malefu Mo- leleki 16-04-202312:00 Poster Area PS029 Poster Session 4d. Molecular diagnostics (incl. POCT and syndromic testing) 12:00 Malefu Moleleki (1, 2), Pieter Nel (1, 3), Kessendri Reddy (1, 3), Siphiwe Matukane (1, 3), Stephanie Cloete (1), Zayaan Abrahams (1), Nicole Wolter (4), Andrew Whitelaw (1, 3) - (1) Division Of Medical Microbiology, Department Of Pathology, Faculty Of Medicine And Health Sciences, Stellenbosch University, South Africa, (2) Department Of Clinical Microbiology And Infectious Diseases, School Of Pathology, Faculty Of Health Sciences, University Of The Witwatersrand, South Africa, (3) National Health Laboratory Service, Tygerberg Hospital, South Africa, (4) Centre For Respiratory Diseases And Meningitis, National Institute For Communicable Diseases Of The National Health Laboratory Service, South Africa 2316P0524 Same-day detection of antimicrobial resistance in Neisseria gonorrhoeae: proof of concept for seven clinically relevant antibiotics Frida Nilsson15-04-202312:00 Poster Area PS022 Poster Session 3e. Resistance detection / pre- diction approaches (rapid and/ or molecular assays, resistome analysis, inference methods) 12:00 Frida Nilsson (1), Oskar Ekelund (1), Magnus Unemo (2), Christine Carson (3), Sofia Somajo (4) - (1) Dept Of Clinical Microbiology, Region Kronoberg, Sweden, (2) Swedish Reference Laboratory For Sti, Örebro University Hospital, Sweden, (3) School Of Medicine, University Of Western Australia, Australia, (4) Department Of Chemistry And Biomedical Sciences, Linnaeus University, SwedenFINAL PROGRAMME – 33RD ECCMID Copenhagen, Denmark 2023 9 CategorySub-categoryLink AbstractsLink EposterLink Oral Session 01. Viral infection & disease (non CO- VID-19) 1b. Viral hepatitis (incl. diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13461&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2826 al Universitario Basurto, Spain, (2) Biocruces-Bizkaia Health Institute, Spain 09. Experimental microbiology, micro- bial pathogenesis & biofilm 9a. Microbial pathogenesis & virulence https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13462&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0937 nology, Microbiology And Parasitology, Faculty Of Pharmacy, University Of The Basque Country Upv/Ehu, Spain, (2) Bioaraba, Clinical Microbiology, Vitoria-Gasteiz, Spain; Osakidetza, Basque Health Service, University Hospital Of Alava, Microbiology Service, Intensive 05. New antibacte- rial agents, PK/PD & Stewardship 5b. Pharmacokinetics/pharmacody- namics of antibacterial drugs & thera- peutic drug monitoring https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13463&preview=1&aig=-1https://online.eccmid.org/programme-live-1?coday=2023-04-15&openSession=OS059 oche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Switzerland, (3) Roche Pharma Research And Early Development, Immunology, Infectious Disease And Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Switzerland 05. New antibacte- rial agents, PK/PD & Stewardship 5b. Pharmacokinetics/pharmacody- namics of antibacterial drugs & thera- peutic drug monitoring https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13464&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2207 lagro Montero (1), Santiago Grau (1), Juan Pablo Horcajada (1) - (1) Hospital Del Mar, Spain, (2) Hospital 12 De Octubre, Spain 02. Bacterial infection & disease 2f. Community acquired nervous sys- tem and other multi-system bacterial infections (incl. epidemiology, clinical, imaging, treatment & prevention) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13465&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1424 02. Bacterial infection & disease 2d. Community-acquired abdominal/ gastrointestinal, urinary tract & genital infections (incl. epidemiology, clinical, imaging, treatment & prevention) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13466&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1379 University Hospital Of Southern Denmark, Denmark, (2) Department Of Clinical Research, University Hospital Of Southern Denmark, Denmark, (3) Department Of Paediatrics, University Hospital Of Southern Denmark, Denmark, (4) Department Of Regional Health 03. Bacterial suscepti- bility & resistance 3b. Resistance surveillance & epidemio- logy: Gram-negatives https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13467&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0142 12. COVID-19 12d. Diagnostics (incl. molecular, geno- mic, rapid tests) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13468&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2580 gación Sanitaria Aragón (Iis Aragón), Biomedical Research Centre Of Aragón (Ciba), Spain, (2) Instituto De Carboquímica Icb-Csic, Spain, (3) Servicio De Enfermedades Infecciosas, Hospital Clínico Universitario Lozano Blesa, Spain, (4) Biobank Of The Aragon Health Y Salud Pública, Área De Inmunología, Facultad De Medicina, Universidad De Zaragoza, Spain 06. Fungal infection & disease 6d. Antifungal drugs & treatment (incl. clinical trials) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13469&preview=1&aig=-1https://online.eccmid.org/programme-live-1?coday=2023-04-18&openSession=OS233 ain, (2) Departamento De Microbiología, Pediatría, Radiología Y Salud Pública, Área De Inmunología, Facultad De Medicina, Universidad De Zaragoza, Spain, (3) Instituto De Biocomputación Y Física De Sistemas Complejos (Bifi), Universidad De Zaragoza, Spain, (4) 05. New antibacte- rial agents, PK/PD & Stewardship 5d. Antimicrobial stewardship and pre- scribing (incl. interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13472&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=E0220https://online.eccmid.org/programme-live-1?coday=2023-04-15&openSession=EF048 h Africa, (2) Pgimer, India, (3) Imperial College London, United Kingdom, (4) Amrita Hospital, India, (5) Gardp, Switzerland 02. Bacterial infection & disease 2g. Zoonotic bacterial infections (incl. foodborne, waterborne and vector-bor- ne pathogens, veterinary microbiology and One Health aspects, excl. AMR) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13473&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1459 el Principado De Asturias (Ispa) . Hospital Universitario Central De Asturias (Huca), Spain, (3) University Of Santiago De Compostela (Usc), Spain, (4) German Federal Institute For Risk Assessment (Bfr), Germany 03. Bacterial suscepti- bility & resistance 3g. Spread of resistance incl. carriage, reservoirs, ecology, models (excl. noso- comial transmission) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13474&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0633 mosfera, Portugal, (3) Université De Fribourg, Switzerland, (4) Escola Superior De Saúde Da Cruz Vermelha Portuguesa-Lisboa, Portugal 03. Bacterial suscepti- bility & resistance 3g. Spread of resistance incl. carriage, reservoirs, ecology, models (excl. noso- comial transmission) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13475&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0601 United Kingdom, (3) North Bristol Nhs Trust, United Kingdom, (4) United Kingdom Health Security Agency, United Kingdom 02. Bacterial infection & disease 2c. Community-acquired respiratory infections (incl. epidemiology, clinical, imaging, treatment & prevention) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13476&preview=1&aig=-1https://online.eccmid.org/programme-live-1?coday=2023-04-16&openSession=OS086 04. Diagnostic micro- biology 4d. Molecular diagnostics (incl. POCT and syndromic testing) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13477&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1712 nd Health Sciences, Stellenbosch University, South Africa, (2) Department Of Clinical Microbiology And Infectious Diseases, School Of Pathology, Faculty Of Health Sciences, University Of The Witwatersrand, South Africa, (3) National Health Laboratory Service, 03. Bacterial suscepti- bility & resistance 3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13478&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0524 iversity Of Western Australia, Australia, (4) Department Of Chemistry And Biomedical Sciences, Linnaeus University, SwedenNext >